Walleye Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-627
Closed -$16.8K 5106
2025
Q3
$16.8K Sell
627
-11,078
-95% -$264K ﹤0.01% 4227
2025
Q2
$196K Sell
11,705
-57,323
-83% -$1.01M ﹤0.01% 3384
2025
Q1
$1.22M Buy
69,028
+62,642
+981% +$1.26M 0.01% 1809
2024
Q4
$155K Buy
+6,386
New +$182K ﹤0.01% 3913
2024
Q3
Sell
-17,442
Closed -$650K 5833
2024
Q2
$830K Buy
17,442
+10,628
+156% +$466K ﹤0.01% 3032
2024
Q1
$261K Sell
6,814
-21,456
-76% -$698K ﹤0.01% 3774
2023
Q4
$882K Buy
+28,270
New +$1.02M ﹤0.01% 2460
2023
Q1
Sell
-62,850
Closed -$3.05M 4337
2022
Q4
$3.05M Buy
62,850
+47,864
+319% +$3M 0.06% 405
2022
Q3
$1.06M Buy
14,986
+8,957
+149% +$767K 0.02% 932
2022
Q2
$428K Buy
+6,029
New +$388K 0.01% 1127
2022
Q1
Sell
-8,362
Closed -$763K 2579
2021
Q4
$763K Buy
8,362
+4,432
+113% +$476K 0.02% 739
2021
Q3
$505K Buy
3,930
+2,398
+157% +$336K 0.01% 782
2021
Q2
$234K Buy
+1,532
New +$202K 0.01% 1022
2021
Q1
Sell
-14,300
Closed -$1.13M 1337
2020
Q4
$1.13M Buy
14,300
+7,848
+122% +$574K 0.08% 256
2020
Q3
$365K Buy
+6,452
New +$347K 0.04% 461

Other funds holding STAA

Walleye Capital's STAA Position: Q4 2025 in Review

Walleye Capital sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 627 shares — an estimated $16.8K sold.

Walleye Capital first reported a position in STAA in Q3 2020 and held it in 15 quarters. The position peaked at $3.05M in Q4 2022. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

  • Walleye Capital reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 627 STAAR Surgical shares in Q4 2025, an estimated $16.8K.
  • Walleye Capital first reported a position in STAAR Surgical in Q3 2020 and held it in 15 quarters.
  • Walleye Capital's STAAR Surgical position peaked at $3.05M in Q4 2022.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.